Mechanistically, YTHDF1-mediated recognition of m6A-modified EGFR mRNA enhanced its translation, supporting the rationale for targeting m6A machinery in combination with EGFR inhibitors to prevent metastasis in HCC after RFA [247]. This evidence concerns the gene EGFR and hepatocellular carcinoma.